SCIENTIFIC AND TECHNOLOGICAL FORECASTING OF SPECIES Combretum duarteanum Cambess AND Combretum mellifluum Eichler
The genus Combretum is native of the northeast of Brazil, and is the largest of the Combretaceae family, with 370 species with tropical and subtropical distribution. Plants of this gender are employed in the treatment of cancer, leprosy, back pain, headache, colds, female infertility, heart diseases, scorpio and snake bites, infections, diabetes, malaria, bleeding, digestive disorders and diuretic diseases. Two species of this gender, Combretum duarteanum and C. mellifluum were chosen for the study and their scientific names were used as key words. The technological and scientific propects were developed with electronic databases: European Patente Office (EPO), World Intellectual Property Organization (WIPO), United States Patent and Trademark Office (USPTO), Derwent Innovations Index® (DII), Banco Latinoamericano de Patentes (LATIPAT) Instituto Nacional de Propriedade Intelectual (INPI), Pubmed, ScienceDirect, Web of Science, ScinFinder e Periódicos Capes. No registration of patents was found for the species. The articles found in the databases Pubmed, ScinFinfer and Periodicals Capes with the species C. duarteanum are related to the same works, with the exception of the Periódicos Capes which has one more work. There are no published articles for the species C. mellifluum. Due to a gap observed in the prospection developed with the species C. duarteanum and C. mellifluum, their study is necessary to broaden the chemical and phamacological knowledge supplying data that will contribute to broaden their understanding, and also valorize the biodiversity and preservation of the species and its environment.